Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future
2012; Wiley; Volume: 53; Issue: 1 Linguagem: Inglês
10.1111/j.1537-2995.2012.03708.x
ISSN1537-2995
AutoresMark E. Brecher, Morris A. Blajchman, Roslyn Yomtovían, Paul M. Ness, James P. AuBuchon,
Tópico(s)Platelet Disorders and Treatments
ResumoTransfusionVolume 53, Issue 1 p. 221-231 COMMENTARY Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future Mark E. Brecher, Corresponding Author Mark E. Brecher From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Mark E. Brecher, MD, FCAP, Chief Medical Officer, Laboratory Corporation of America, 531 South Spring Street, Burlington, NC 27215; e-mail: [email protected].Search for more papers by this authorMorris A. Blajchman, Morris A. Blajchman From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this authorRoslyn Yomtovian, Roslyn Yomtovian From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this authorPaul Ness, Paul Ness From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this authorJames P. AuBuchon, James P. AuBuchon From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this author Mark E. Brecher, Corresponding Author Mark E. Brecher From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Mark E. Brecher, MD, FCAP, Chief Medical Officer, Laboratory Corporation of America, 531 South Spring Street, Burlington, NC 27215; e-mail: [email protected].Search for more papers by this authorMorris A. Blajchman, Morris A. Blajchman From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this authorRoslyn Yomtovian, Roslyn Yomtovian From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this authorPaul Ness, Paul Ness From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this authorJames P. AuBuchon, James P. AuBuchon From the Laboratory Corporation of America, Burlington, North Carolina; the Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, North Carolina; McMaster University, Hamilton, Ontario, Canada; the Department of Pathology (Transfusion Medicine), Case Western Reserve University School of Medicine, and the Department of Pathology and Laboratory Medicine, Louis Stokes VA Medical Center, Cleveland, Ohio; Johns Hopkins University, Baltimore, Maryland; and Puget Sound Blood Center and the University of Washington, Seattle, Washington.Search for more papers by this author First published: 21 May 2012 https://doi.org/10.1111/j.1537-2995.2012.03708.xCitations: 44Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume53, Issue1January 2013Pages 221-231 RelatedInformation
Referência(s)